PODD

Insulet

$312.89

-20.58 (-6.17%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$373.58
(+19.4%)
Strong Buy: 5
Buy: 17
Hold: 3
Sell: 0
Strong Sell: 0
Description:
Insulet Corporation (PODD) is a leading innovator in insulin delivery solutions, dedicated to enhancing the quality of life for individuals with insulin-dependent diabetes. Based in Acton, Massachusetts, the company is renowned for its Omnipod® Insulin Management System, which revolutionizes diabetes care with its tubeless and wearable design that offers unparalleled flexibility and user experience. Committed to continuous innovation and expanding its global footprint, Insulet is positioned at the forefront of the healthcare industry, driving advancements in diabetes management technology and striving to transform the standard of care for diabetes patients worldwide.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
100 NAGOG PARK, ACTON, MA, UNITED STATES, 01720
Fiscal year end:
December
Market capitalization:
$23.5 Billion
EBITDA:
$511 Million
PERatio:
95.28
EPS:
3.5
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.379

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+947%
How much will you get:
$10,469
Prices dates:
30-10-2015: $29.90 and 31-10-2025: $313.01